Deflazacort

Deflazacort (Cas No.: 14484-47-0) is derivative of prednisolone and a glucocorticoid-class corticosteroid which is mainly used to treat inflammation and autoimmune conditions. Deflazacort I widely used to prevent diseases such as rheumatoid arthritis , asthma, Duchenne muscular dystrophy (DMD) , inflammatory bowel diseases, and carious allergic disorders.

Deflazacort shows potent anti-inflammatory and immunosuppressive effects with reduce tendency to cause weight gain and bone demineralization as compared to other corticosteroids. Deflazacort act by suppressing the release of inflammatory mediators and modulating immune system responses due to which it is highly effective in both acute and chronic conditions.

Chemox Pharma is leading manufacturer of Deflazacort [CAS No: 14484-47-0] and ensures high-purity products with highest level of compliance. Chemox Pharma offers global regulatory supports and reliable supply chain solutions – establishing us as a trusted partner by pharmaceutical companies over 90 countries, reflecting global footprints and reputation.